VEEV250117P220000
- 7.10
- +2.35+49.47%
Veeva Systems Newsroom
Stephens Initiates Veeva Systems(VEEV.US) With Buy Rating, Announces Target Price $280
Veeva Systems Analyst Ratings
Veeva Systems Is Maintained at Underweight by Morgan Stanley
Morgan Stanley Maintains Veeva Systems(VEEV.US) With Sell Rating, Raises Target Price to $195
Morgan Stanley Sticks to Its Sell Rating for Veeva Systems (VEEV)
Veeva Systems Analyst Ratings
JP Morgan Maintains Neutral on Veeva Systems, Raises Price Target to $218
Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Conmed (CNMD) and Veeva Systems (VEEV)
Morgan Stanley Maintains Veeva Systems(VEEV.US) With Sell Rating, Maintains Target Price $183
Customer attrition has led to a decline in Veeva (VEEV.US) stock prices. Baird reassures the market: the financial impact is manageable and maintains a "Shareholding" rating.
Truist Financial Keeps Their Hold Rating on Veeva Systems (VEEV)
Truist Financial Maintains Veeva Systems(VEEV.US) With Hold Rating, Maintains Target Price $261
Veeva Systems Analyst Ratings
Veeva Systems Is Maintained at Outperform by Mizuho
Mizuho Securities Maintains Veeva Systems(VEEV.US) With Buy Rating, Announces Target Price $280
Citi Maintains Veeva Systems(VEEV.US) With Buy Rating, Raises Target Price to $307
A Quick Look at Today's Ratings for Veeva Systems(VEEV.US), With a Forecast Between $183 to $300
Barclays Maintains Overweight on Veeva Systems, Raises Price Target to $275
Evercore ISI Group Maintains In-Line on Veeva Systems, Raises Price Target to $245
KeyBanc Raises Veeva Systems Price Target to $285 From $240, Maintains Overweight Rating